Ledger.Open graph →

SEC Form D · filed November 23, 2016

NeuroRx, Inc

Offering

$5.5M

Sold

$4.5M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WILMINGTON, DE

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Chaim Hurvitz · Tel Aviv, L3Director Jonathan Javitt · Wilmington, DEExec · Director James Lawrence · Minneapolis, MNDirector Sherry Glied · New York, NYDirector Daniel Javitt · Fort Lee, NJDirector John Partridge · Sausalito, CADirector Thomas Kosasa · EDEN PRARIE, MNDirector Daniel M. Friedman · New York, NYExec · Director Elliott Deloach · Sausalito, CADirector Andrew Weinstein · Sausalito, CADirector Fernando De Leon · DALLAS, TXExec · Director Nabyl Charania · MIAMI, FLDirector German Montoya · MIAMI, FLDirector Charles N. Corfield · BOULDER, CODirector Larry A. Schwartz · BOULDER, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗